2min chapter

The HemOnc Pulse cover image

Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma

The HemOnc Pulse

CHAPTER

Relapsed GVD - What's Next?

checkpoint inhibitors, many of us use them at relapsed. And we saw Alison Moskowitz present data on Pembroke GVD a year or so ago now. It was relatively small numbers, about 35 patients, very high response rate. I think it was an 89% overall response. The vast majority got to autographed. Their one year PFS was 90%. So, you know, it's a one year follow up. But of course, most relapses happened within a year. That was quite clear from the etheria study, much larger study done several years ago now.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode